| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Chief Operating Officer
2 companies
Michael K Handley is Chief Executive Officer at VBIO, with reported holdings spanning 2 companies. Michael K Handley's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $6K at current prices.
Michael K Handley's largest disclosed position is in VBIO as Chief Executive Officer, worth about $6K.
Michael K Handley has 4 Form 4 filings on record from February 2025 to May 2026, across 2 companies: Chief Executive Officer at Valion Bio (VBIO), 2026; Chief Operating Officer at Tivic Health Systems (TIVC), 2025–2026.
The 4 reported transactions were 2 option exercises and 2 option or other derivative awards.
There are no priced open-market purchases or sales on record, so none of these filings shows a decision to buy or sell shares in the market.
No transactions found
Try adjusting your filters or search criteria